Showing results (71-80 of 210) with videos related to

Sort By:
Pageof 21
Clinical Rheumatology|October 3, 2020
Psoriatic arthritis and depressive symptoms: does systemic inflammation play a role?Enrico De Lorenzis, Gerlando Natalello, Dario Bruno, et al.
International Journal of Molecular Sciences|March 28, 2024
B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory StudyDario Bruno, Barbara Tolusso, Gianmarco Lugli, et al.
Frontiers in Medicine|March 18, 2021
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label StudyDario Bruno, Anna Laura Fedele, Barbara Tolusso, et al.
Annals of the Rheumatic Diseases|January 26, 2017
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?Stefano Alivernini, Barbara Tolusso, Luca Petricca, et al.
Endocrine|October 17, 2018
Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserveClara Di Mario, Luca Petricca, Maria Rita Gigante, et al.
European Journal of Internal Medicine|October 28, 2018
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective studySilvia Bosello, Giacomo De Luca, Giorgia Berardi, et al.
Endocrine|December 4, 2018
Correction to: Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: influence of the disease severity and therapy on the ovarian reserveClara Di Mario, Luca Petricca, Maria Rita Gigante, et al.
Frontiers in Medicine|August 21, 2018
Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid ArthritisBarbara Tolusso, Maria Rita Gigante, Stefano Alivernini, et al.
Rheumatology (Oxford, England)|October 6, 2018
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus ConferenceFabrizio Conti, Fabiola Atzeni, Laura Massaro, et al.
Arthritis and Rheumatism|November 1, 2006
Hepatocyte growth factor and transforming growth factor beta1 ratio at baseline can predict early response to cyclophosphamide in systemic lupus erythematosus nephritisAnna Capuano, Stefano Costanzi, Giusy Peluso, et al.
Pageof 21